BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32380676)

  • 1. Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers.
    Siskova A; Cervena K; Kral J; Hucl T; Vodicka P; Vymetalkova V
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
    J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
    Slaby O
    Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
    Igder S; Mohammadiasl J; Mokarram P
    Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
    Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
    Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future molecular diagnostics in colorectal cancer and colorectal adenoma.
    Tsang AH; Cheng KH; Wong AS; Ng SS; Ma BB; Chan CM; Tsui NB; Chan LW; Yung BY; Wong SC
    World J Gastroenterol; 2014 Apr; 20(14):3847-57. PubMed ID: 24744577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.
    Wu CW; Ng SC; Dong Y; Tian L; Ng SS; Leung WW; Law WT; Yau TO; Chan FK; Sung JJ; Yu J
    Clin Cancer Res; 2014 Jun; 20(11):2994-3002. PubMed ID: 24691020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
    Lind GE; Danielsen SA; Ahlquist T; Merok MA; Andresen K; Skotheim RI; Hektoen M; Rognum TO; Meling GI; Hoff G; Bretthauer M; Thiis-Evensen E; Nesbakken A; Lothe RA
    Mol Cancer; 2011 Jul; 10():85. PubMed ID: 21777459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adenoma hunt in colorectal cancer screening: defining the target.
    Sillars-Hardebol AH; Carvalho B; van Engeland M; Fijneman RJ; Meijer GA
    J Pathol; 2012 Jan; 226(1):1-6. PubMed ID: 21984228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
    BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the clinical performance of
    Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W
    Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
    Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
    PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.